...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BMC Health Services Research >Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee
【24h】

Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee

机译：病人对明智清单的了解和态度-斯德哥尔摩药物与治疗委员会的药物配方

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Involving patients in decisions about their pharmacotherapy is crucial for a satisfactory treatment outcome. Information and opinions about medicines are available from a variety of sources. The Wise List is the drug formulary of recommended essential medicines for the Stockholm healthcare region and is issued by the Drug and Therapeutics Committee (DTC). To inform the public about treatment for common diseases and the concept of recommended medicines, a patient edition of the Wise List was developed. The aim of this study was to explore patients’ knowledge, needs and attitudes to the Wise List, DTC and information about medicines in general. To examine patient knowledge about recommended medicines a survey (n?=?312) was carried out at four large primary healthcare centres in Stockholm, Sweden. To further elucidate the patients’ needs of the information on recommended medicines and medicines in general, three focus group discussions (FGDs) were performed. Of the respondents 57% did not recognise the Wise List, 26% recognised but did not use it and 17% used it. A total of 63% reported that they search for information about medicines. The most common information source was “asking their doctor” (36%) followed by searching the internet (31%). The FGDs revealed that the patients were not interested in medicines in general, only in the medicines they use themselves. They did not understand the aim of the Wise List or how they could benefit from information about recommended medicines. The patients expressed a wish to access all information they need about their own care as well as public healthcare information at one location. The intended aim of the DTC with providing information to the public was not achieved as the patients have difficulties to understand the information and how they should use it. The patients were not interested in medicines in general, they wanted information tailored to their specific needs. The findings highlight the importance of creating tools for patients in collaboration with them and evaluate the concept continuously.
机译：使患者参与有关其药物治疗的决策对于获得满意的治疗结果至关重要。有关药物的信息和意见可从多种来源获得。明智清单是斯德哥尔摩医疗保健地区推荐的基本药物的药物配方，由药物和治疗委员会（DTC）发布。为了向公众介绍常见疾病的治疗方法和推荐药物的概念，开发了《明智清单》的患者版本。这项研究的目的是探讨患者对明智清单，DTC和一般药物信息的知识，需求和态度。为了检查患者对推荐药物的了解，在瑞典斯德哥尔摩的四个大型初级保健中心进行了一项调查（n = 312）。为了进一步阐明患者对推荐药物和一般药物信息的需求，进行了三个焦点小组讨论（FGD）。在受访者中，有57％的人未识别明智名单，有26％的人承认但未使用明智名单，有17％的人未意识到。共有63％的人报告他们搜索有关药物的信息。最常见的信息来源是“请教医生”（36％），其次是互联网搜索（31％）。 FGDs表明患者一般对药物不感兴趣，仅对他们自己使用的药物感兴趣。他们不了解《明智清单》的目的，也不了解如何从推荐药物信息中受益。患者表示希望在一个位置访问他们需要的有关自己的护理的所有信息以及公共医疗保健信息。由于患者难以理解信息以及如何使用信息，因此无法实现DTC向公众提供信息的预期目的。患者通常对药物不感兴趣，他们希望获得适合其特定需求的信息。研究结果强调了与患者合作创建工具并不断评估概念的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号